190 related articles for article (PubMed ID: 30125623)
1. The Atxn7-overexpressing mice showed hyperactivity and impulsivity which were ameliorated by atomoxetine treatment: A possible animal model of the hyperactive-impulsive phenotype of ADHD.
Dela Peña IJI; Botanas CJ; de la Peña JB; Custodio RJ; Dela Peña I; Ryoo ZY; Kim BN; Ryu JH; Kim HJ; Cheong JH
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jan; 88():311-319. PubMed ID: 30125623
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional profiling of SHR/NCrl prefrontal cortex shows hyperactivity-associated genes responsive to amphetamine challenge.
Dela Peña IJI; Dela Peña I; de la Peña JB; Kim HJ; Sohn A; Shin CY; Han DH; Kim BN; Ryu JH; Cheong JH
Genes Brain Behav; 2017 Sep; 16(7):664-674. PubMed ID: 28422445
[TBL] [Abstract][Full Text] [Related]
3. Atomoxetine for hoarding disorder: A pre-clinical and clinical investigation.
Grassi G; Micheli L; Di Cesare Mannelli L; Compagno E; Righi L; Ghelardini C; Pallanti S
J Psychiatr Res; 2016 Dec; 83():240-248. PubMed ID: 27665536
[TBL] [Abstract][Full Text] [Related]
4. Atomoxetine reduces hyperactive/impulsive behaviours in neurokinin-1 receptor 'knockout' mice.
Pillidge K; Porter AJ; Vasili T; Heal DJ; Stanford SC
Pharmacol Biochem Behav; 2014 Dec; 127():56-61. PubMed ID: 25450119
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of the Thyroid Hormone-Responsive (THRSP) Gene in the Striatum Leads to the Development of Inattentive-like Phenotype in Mice.
Custodio RJP; Botanas CJ; de la Peña JB; Dela Peña IJ; Kim M; Sayson LV; Abiero A; Ryoo ZY; Kim BN; Kim HJ; Cheong JH
Neuroscience; 2018 Oct; 390():141-150. PubMed ID: 30138648
[TBL] [Abstract][Full Text] [Related]
6. Atomoxetine reverses locomotor hyperactivity, impaired novel object recognition, and prepulse inhibition impairment in mice lacking pituitary adenylate cyclase-activating polypeptide.
Shibasaki Y; Hayata-Takano A; Hazama K; Nakazawa T; Shintani N; Kasai A; Nagayasu K; Hashimoto R; Tanida M; Katayama T; Matsuzaki S; Yamada K; Taniike M; Onaka Y; Ago Y; Waschek JA; Köves K; Reglődi D; Tamas A; Matsuda T; Baba A; Hashimoto H
Neuroscience; 2015 Jun; 297():95-104. PubMed ID: 25841321
[TBL] [Abstract][Full Text] [Related]
7. Impulsivity in Alcohol-Dependent Patients with and without ADHD: The Role of Atomoxetine.
Coppola M; Mondola R
J Psychoactive Drugs; 2018; 50(4):361-366. PubMed ID: 29877779
[TBL] [Abstract][Full Text] [Related]
8. Methylphenidate and Atomoxetine-Responsive Prefrontal Cortical Genetic Overlaps in "Impulsive" SHR/NCrl and Wistar Rats.
Dela Peña I; Dela Peña IJ; de la Peña JB; Kim HJ; Shin CY; Han DH; Kim BN; Ryu JH; Cheong JH
Behav Genet; 2017 Sep; 47(5):564-580. PubMed ID: 28744604
[TBL] [Abstract][Full Text] [Related]
9. Effect of atomoxetine on hyperactivity in an animal model of attention-deficit/hyperactivity disorder (ADHD).
Moon SJ; Kim CJ; Lee YJ; Hong M; Han J; Bahn GH
PLoS One; 2014; 9(10):e108918. PubMed ID: 25271814
[TBL] [Abstract][Full Text] [Related]
10. Droxidopa alters dopamine neuron and prefrontal cortex activity and improves attention-deficit/hyperactivity disorder-like behaviors in rats.
Dela Peña I; Shen G; Shi WX
Eur J Pharmacol; 2021 Feb; 892():173826. PubMed ID: 33347825
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of ADHD medications on impulsive action in the mouse 5-choice serial reaction time task.
Fitzpatrick CM; Andreasen JT
Eur J Pharmacol; 2019 Mar; 847():123-129. PubMed ID: 30690006
[TBL] [Abstract][Full Text] [Related]
12. Candidate genetic pathways for attention-deficit/hyperactivity disorder (ADHD) show association to hyperactive/impulsive symptoms in children with ADHD.
Bralten J; Franke B; Waldman I; Rommelse N; Hartman C; Asherson P; Banaschewski T; Ebstein RP; Gill M; Miranda A; Oades RD; Roeyers H; Rothenberger A; Sergeant JA; Oosterlaan J; Sonuga-Barke E; Steinhausen HC; Faraone SV; Buitelaar JK; Arias-Vásquez A
J Am Acad Child Adolesc Psychiatry; 2013 Nov; 52(11):1204-1212.e1. PubMed ID: 24157394
[TBL] [Abstract][Full Text] [Related]
13. Effect of ADHD medication in male C57BL/6J mice performing the rodent Continuous Performance Test.
Caballero-Puntiverio M; Lerdrup LS; Grupe M; Larsen CW; Dietz AG; Andreasen JT
Psychopharmacology (Berl); 2019 Jun; 236(6):1839-1851. PubMed ID: 30656365
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of hyperactivity and impulsivity by carbonic anhydrase inhibitors in spontaneously hypertensive rats, an animal model of ADHD.
Yang MT; Lu DH; Chen JC; Fu WM
Psychopharmacology (Berl); 2015 Oct; 232(20):3763-72. PubMed ID: 26228972
[TBL] [Abstract][Full Text] [Related]
15. Effect of Atomoxetine Treatment on Reading and Phonological Skills in Children with Dyslexia or Attention-Deficit/Hyperactivity Disorder and Comorbid Dyslexia in a Randomized, Placebo-Controlled Trial.
Shaywitz S; Shaywitz B; Wietecha L; Wigal S; McBurnett K; Williams D; Kronenberger WG; Hooper SR
J Child Adolesc Psychopharmacol; 2017 Feb; 27(1):19-28. PubMed ID: 27410907
[TBL] [Abstract][Full Text] [Related]
16. Similar effects of the selective noradrenaline reuptake inhibitor atomoxetine on three distinct forms of impulsivity in the rat.
Robinson ES; Eagle DM; Mar AC; Bari A; Banerjee G; Jiang X; Dalley JW; Robbins TW
Neuropsychopharmacology; 2008 Apr; 33(5):1028-37. PubMed ID: 17637611
[TBL] [Abstract][Full Text] [Related]
17. Lister hooded rats as a novel animal model of attention-deficit/hyperactivity disorder.
Jogamoto T; Utsunomiya R; Sato A; Kihara N; Choudhury ME; Miyanishi K; Kubo M; Nagai M; Nomoto M; Yano H; Shimizu YI; Fukuda M; Ishii E; Eguchi M; Tanaka J
Neurochem Int; 2020 Dec; 141():104857. PubMed ID: 33010392
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of methylphenidate and atomoxetine on intrinsic brain activity in children with attention deficit hyperactivity disorder.
Shang CY; Yan CG; Lin HY; Tseng WY; Castellanos FX; Gau SS
Psychol Med; 2016 Nov; 46(15):3173-3185. PubMed ID: 27574878
[TBL] [Abstract][Full Text] [Related]
19. Relationship between two forms of impulsivity in mice at baseline and under acute and sub-chronic atomoxetine treatment.
Kyriakidou M; Caballero-Puntiverio M; Andreasen JT; Thomsen M
Prog Neuropsychopharmacol Biol Psychiatry; 2023 Dec; 127():110841. PubMed ID: 37586638
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of atomoxetine and methylphenidate for problematic online gaming in adolescents with attention deficit hyperactivity disorder.
Park JH; Lee YS; Sohn JH; Han DH
Hum Psychopharmacol; 2016 Nov; 31(6):427-432. PubMed ID: 27859666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
